Feed RSS de Policy papers and consultations from Medicines and Healthcare products Regulatory Agency (MHRA)

Qui segueix Policy papers and consultations from Medicines and Healthcare products Regulatory Agency (MHRA) també segueix

• PMDA：国際関係業務 すべて pmda.go.jp
• Swissmedic RSS Feed Content – Neu auf der Website swissmedic.ch
• 제개정고시등 mfds.go.kr
• PMDA：トップ 承認審査 pmda.go.jp
• Agency IQ agencyiq.com
• 입법/행정예고 mfds.go.kr
• ICH Public | News admin.ich.org
• Regulatory Focus | RAPS raps.org

Més feeds RSS de gov.uk

• News and communications https://www.gov.uk/search/news-and-communications.atom
• Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom
• News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) https://www.gov.uk/search/news-and-communications.atom?organisations%5B%5D=medicines-and-healthcare-products-regulatory-agency
• Alerts and recalls for drugs and medical devices https://www.gov.uk/drug-device-alerts.atom
• HM Treasury - Activity on GOV.UK https://www.gov.uk/government/organisations/hm-treasury.atom
• Russian invasion of Ukraine: UK government response - Activity on GOV.UK https://www.gov.uk/government/topical-events/russian-invasion-of-ukraine-uk-government-response.atom
• Department for Education - Activity on GOV.UK https://www.gov.uk/government/organisations/department-for-education.atom
• Department for Transport - Activity on GOV.UK https://www.gov.uk/government/organisations/department-for-transport.atom

Mostra tots els feeds RSS de gov.uk

Més feeds RSS per explorar

• ClinicalTrials.gov: Inflammatory Bowel Diseases | Phase 2, 3, 4, Not Applicable | Industry | First posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: "HER2+" OR "HER2-positive" OR "HER2 positive" OR ERBB2 OR "human epidermal growth factor receptor 2" OR "HER2/neu" OR "c-erbB2" | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: "HER2-low" OR "HER2 low" OR "HER2low" OR "HER2 expression" OR "HER2 expressor" OR "HER2 amplification" OR "HER2 amplified" OR "HER2 overexpression" OR "HER2 overexpressed" | Last update posted in the last 14 days clinicaltrials.gov